Humana Inc. ($HUM) Stock Forecast: Down 7.3% Today

What is Humana Inc.?

Humana Inc. (NYSE: HUM) is a leading health insurance company based in Louisville, Kentucky. The company offers a wide range of healthcare products and services to its customers.

Why is Humana Inc. going down?

HUM stock is down 7.3% on Nov 5, 2025 20:42

• Despite surpassing Q3 earnings expectations and showing robust premium growth, Humana stock underwent a bearish trend.
• The negative market response may be attributed to increased expenses and declining memberships affecting the company’s performance, notwithstanding the positive earnings and revenue outcomes.
• Shareholders may have expressed dissatisfaction with the lower quarterly earnings per share in comparison to the previous year, falling short of analysts' projections.
• The fluctuating U.S. stock futures market and attention directed towards other companies such as McDonald's might have also influenced the downward movement in Humana stock today.

HUM Price Chart

HUM Technical Analysis

HUM News

Humana Beats Q3 Earnings on Premium Growth, Updates 2025 View

HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.

https://www.zacks.com/stock/news/2786036/humana-beats-q3-earnings-on-premium-growth-updates-2025-view

Why Is Humana Stock Plunging Today - Humana ( NYSE:HUM )

Humana Inc. ( NYSE:HUM ) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82. The company reported sales of $32.65 billion, up from $29.39 billion a year ago, beating the consensus of $32.01 billion.

https://www.benzinga.com/markets/earnings/25/11/48657884/humana-q3-premium-growth-offsets-membership-drop-stock-tumbles

Humana ( HUM ) Beats Q3 Earnings and Revenue Estimates

Humana (HUM) delivered earnings and revenue surprises of +11.34% and +2.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2785395/humana-hum-beats-q3-earnings-and-revenue-estimates

Top Wall Street Forecasters Revamp Humana Expectations Ahead Of Q3 Earnings - Humana ( NYSE:HUM )

Humana Inc. ( NYSE:HUM ) will release earnings results for the third quarter before the opening bell on Wednesday, Nov. 5. Analysts expect the Louisville, Kentucky-based company to report quarterly earnings at $2.82 per share, down from $4.16 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/11/48645941/top-wall-street-forecasters-revamp-humana-expectations-ahead-of-q3-earnings

McDonald's, Pinterest And 3 Stocks To Watch Heading Into Wednesday - McDonald's ( NYSE:MCD )

With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects McDonald's Corp. ( NYSE:MCD ) to report quarterly earnings at $3.33 per share on revenue of $7.09 billion before the opening bell, according ...

https://www.benzinga.com/markets/equities/25/11/48645650/mcdonalds-pinterest-and-3-stocks-to-watch-heading-into-wednesday

Trending Today

ZCash ($ZEC) Crypto Forecast: Down 13.5% Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Humana Inc. Price History

02.09.2025 - HUM Stock was down 0.2%

• Humana's stock experienced a bearish movement today, possibly due to:
• Pressure from high benefit ratios and costs impacting the company's profitability.
• Investor concerns raised by an investigation initiated by Bragar Eagel & Squire, P.C., leading to a loss in investor confidence.
• Despite benefiting from rising premiums and Medicare growth, these positive factors might have been overshadowed by the negative aspects, contributing to the bearish trend.
• The comparison with Akero Therapeutics, Inc. might have also influenced investor sentiment, especially if Akero Therapeutics has been outperforming Humana in the sector, leading to a shift in investment focus away from Humana.

10.09.2025 - HUM Stock was down 6.7%

• The bearish movement in Humana's stock today could be attributed to an ongoing investigation, causing uncertainty among investors.
• The news of a competitor expanding its initiative to reduce hospital readmissions may have negatively impacted Humana's stock, signaling increased competition in the healthcare sector.
• Despite a recent jump in Humana's share price, the lack of promising trends in earnings estimate revisions may have contributed to today's bearish movement.
• Investors might be reacting to the overall sentiment in the healthcare industry, leading to a sell-off in Humana's stock amidst uncertainties about the company's future prospects.

02.08.2025 - HUM Stock was up 3.0%

• Humana's strong bullish movement today can be attributed to the company's expansion of musculoskeletal care access through new value-based partnerships. This move not only enhances the company's service offerings but also demonstrates its commitment to improving healthcare outcomes for its members.
• The positive investor sentiment towards Humana may also be fueled by the company's solid financial performance, as indicated by its 19.2% increase since the last earnings report. This growth trajectory suggests that Humana is effectively executing its strategic initiatives and delivering value to its shareholders.
• In contrast, the struggles faced by Centene may have further boosted investor confidence in Humana. The comparison with Centene, which has seen a significant decline in its share price, likely underscored Humana's relative strength and stability in the healthcare sector.

19.08.2025 - HUM Stock was down 5.3%

• The bearish movement in Humana's stock today could be attributed to an investigation initiated by the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., into the officers and directors of the company. This news might have raised concerns among investors about potential legal issues or regulatory challenges that could impact Humana's operations and financial performance.
• The uncertainty surrounding the investigation could have led to a lack of confidence in the company's leadership and governance practices, prompting investors to sell off their positions in Humana's stock.
• As investors typically react negatively to legal investigations and regulatory scrutiny, the bearish trend in Humana's stock today reflects the market's cautious sentiment towards the company's current situation and the potential implications of the ongoing probe.

06.07.2025 - HUM Stock was up 5.4%

• There is an ongoing investigation on behalf of long-term stockholders regarding Humana Inc., which could indicate potential legal issues or concerns within the company.
• Investors who have faced losses with Humana are being advised to consult a litigation attorney, hinting at possible ongoing challenges or uncertainties affecting the stock.
• The positive movement in Humana's stock today could be linked to favorable earnings reports, new business ventures, or market speculation on future growth prospects.
• Despite the investigation and potential losses, investors seem optimistic about Humana's resilience in navigating legal issues and providing value, leading to increased buying activity and a higher stock price.

17.06.2025 - HUM Stock was down 0.3%

• Analysis indicates that Humana's shares are oversold and close to a support level, suggesting a potential turnaround with a upward movement soon.
• Although the stock consolidated on Wednesday, there is hope for a shift from a bearish trend to a bullish rally.
• The downward movement might be due to general market sentiment or industry-specific updates affecting Humana's stock value.
• Traders are advised to monitor any further developments closely to evaluate the possibility of a positive reversal in Humana's stock.

01.09.2025 - HUM Stock was down 4.6%

• The bearish movement in Humana's stock today could be attributed to the unusual options activity indicating that high-rolling investors have taken a bearish stance on the company.
• The investigation by Bragar Eagel & Squire, P.C. on behalf of long-term stockholders might have raised concerns among investors, leading to a sell-off in the stock.
• The comparison with Akero Therapeutics and other medical peers in the sector may have highlighted relative underperformance, further dampening investor sentiment towards Humana.
• Overall, the combination of negative news flow and bearish market sentiment from high-profile investors likely contributed to the significant downward movement in Humana's stock price today.

30.06.2025 - HUM Stock was up 5.4%

• Humana (HUM) reported Q2 earnings that slightly lagged estimates, but revenue exceeded expectations, showing overall positive performance.
• The strength in insurance premiums and Medicare helped offset rising costs and membership declines, indicating resilience in the company's core business.
• Analysts expect Humana to beat earnings estimates, suggesting positive sentiment and potential for the stock to move higher in the near future.
• The combination of positive revenue surprises and expectations of beating earnings estimates likely contributed to the strong bullish movement in Humana's stock today.

30.06.2025 - HUM Stock was up 7.9%

• Humana exceeded Q2 adjusted EPS expectations, showcasing resilience and strong financial performance.
• The company's upward revision of its 2025 revenue forecast to at least $128 billion indicates robust growth prospects and strategic planning.
• Despite some concerns about earnings lagging estimates and rising costs, the overall market sentiment towards Humana seems positive, driven by its solid performance and future growth potential.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing earnings and revenue expectations in the third quarter, Humana's stock faced significant downward pressure.
• Concerns regarding future growth potential may have influenced the market's negative response, despite the company outperforming financially.
• Investors could be considering factors beyond quarterly results, such as future guidance and industry trends, contributing to the stock's bearish performance.
• The presence of a hammer chart pattern and positive trend in earnings estimates, as highlighted elsewhere, might not have been adequate to counter the overall market sentiment impacting Humana's stock.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing Q3 earnings expectations and showing robust premium growth, Humana stock underwent a bearish trend.
• The negative market response may be attributed to increased expenses and declining memberships affecting the company’s performance, notwithstanding the positive earnings and revenue outcomes.
• Shareholders may have expressed dissatisfaction with the lower quarterly earnings per share in comparison to the previous year, falling short of analysts' projections.
• The fluctuating U.S. stock futures market and attention directed towards other companies such as McDonald's might have also influenced the downward movement in Humana stock today.

05.10.2025 - HUM Stock was down 8.7%

• Despite beating Q3 earnings and revenue estimates, Humana's stock experienced a bearish movement, possibly due to analysts revising expectations downwards for the quarter.
• The hammer chart pattern indicating potential support for the stock might not have been enough to offset concerns about the decrease in earnings per share compared to the previous year.
• The focus on rising premiums and service revenues to boost Q3 earnings may not have fully convinced investors, leading to a sell-off in the stock.
• Overall, the mixed market sentiment and cautious outlook from analysts could have contributed to the bearish movement in Humana's stock today.